HLA homozygosity and haplotype bias among patients with chronic lymphocytic leukemia: implications for disease control by physiological immune surveillance
Open Access
- 25 February 2011
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 25 (6), 1036-1039
- https://doi.org/10.1038/leu.2011.30
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- What types of cancers are associated with immune suppression in HIV? Lessons from solid organ transplant recipientsCurrent Opinion in HIV and AIDS, 2009
- Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemiaHuman Immunology, 2008
- Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trialLeukemia, 2008
- Graft‐versus‐leukaemia effect after non‐myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP‐70 in refractory chronic lymphocytic leukaemiaBritish Journal of Haematology, 2007
- Graft-versus-leukemia in chronic lymphocytic leukemiaBone Marrow Transplantation, 2007
- Invited Commentary: Do Clusters of Leukemia and Lymphoma Provide Evidence for an Infectious Cause?American Journal of Epidemiology, 2005
- High occurence of DRB1 11 in chronic lymphocytic leukaemia familiesBritish Journal of Haematology, 2002
- Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREXBlood, 2002
- MHC heterozygosity confers a selective advantage against multiple-strain infectionsProceedings of the National Academy of Sciences, 2002
- Heterozygote advantage for HLA class-II type in hepatitis B virus infectionNature Genetics, 1997